翻译后修改:对心房心肌病变的病变发生的新视角
Pengyu Sun1, Xiyun Bian2, Kuan Wang3
1Medical School of Tianjin University, Tianjin University, Tianjin 300072, China.
The Canadian journal of cardiology
|August 13, 2025
概括
心房心肌病 (AtCM) 涉及到心脏上腔的结构和电气变化. 本综述探讨了蛋白质修饰 (PTM) 如何促进AtCM及其临床潜力.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 心房心肌病 (AtCM) 是一种独特的心血管疾病,涉及心房重塑和功能障碍,与心房动和中风有关.
- AtCM的关键特征包括心房肌病和纤维化,由复杂的相互作用机制驱动.
- 翻译后修饰 (PTMs) 是蛋白质功能的关键调节者,并与AtCM病原发生有关.
研究的目的:
- 审查各种PTM的作用,包括酸化,乙化和无处不在化,在AtCM的发展.
- 探索在AtCM中理解PTM的潜在临床应用.
- 在AtCM和PTM中确定未来的研究方向.
主要方法:
- 在心房心肌病中调查PTM的研究的文献综述.
- 分析特定的PTM (酸化,乙化,无化) 对心房结构和功能的影响.
- 对PTMs在AtCM病变发生中的作用的当前知识的综合.
主要成果:
- 酸化,乙化和无处不在化在AtCM的基础上的分子机制中起着重要作用.
- PTMs影响关键的病理过程,如心房纤维化和肌肉病变.
- 有证据表明,PTM是AtCM进展和严重程度的关键决定因素.
结论:
- PTM在心房心肌病变的病理生理学中发挥着关键作用.
- 准PTM为新的AtCM诊断和治疗提供了有希望的途径.
- 需要进一步的研究,以充分阐明PTM功能和AtCM的临床实用性.
相关概念视频
01:25Cardiomyopathy I: Introduction and Classification
53
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
53
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
48
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
31
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31
01:21Myocarditis I: Introduction
30
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
30
01:30Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22